1.
Fohlin H, Nordenskjöld A, Rosell J, Fernö M, Fornander T, Rydén L, et al. Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up. AO [Internet]. 2024 Jul. 5 [cited 2024 Nov. 4];63(1):535-41. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/40493